NCT02705716 - Study Investigating Efficacy of an Occluding Dentifrice for Dentine Hypersensitivity | Biotech Hunter

Enrollment

409

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

May 20, 2016

Study Completion Date

May 20, 2016

Conditions

Dentin Sensitivity

Interventions

OTHER

0.454% w/w stannous fluoride (1100ppm fluoride)

Dentifrice containing 0.454% w/w stannous fluoride (1100ppm fluoride)

OTHER

0.76% sodium monofluorophosphate (1000ppm fluoride)

Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride)

Trial Locations (3)

GSK Investigational Site, Ellesmere Port

GSK Investigational Site, Manchester

GSK Investigational Site, Metropolitan Borough of Wirral